Hyphema (ICD-11: 9A80) - Complete Coding and Diagnostic Guide

1. Introduction

Hyphema is an ophthalmologic condition characterized by the presence of blood in the anterior chamber of the eye, the space located between the cornea and the iris. This condition represents a significant clinical finding that can range from a small layer of blood visible only on microscopic examination to complete filling of the anterior chamber, known as "black ball hyphema" or total hyphema.

The clinical importance of hyphema lies not only in its alarming visual presentation, but mainly in the potential complications it can cause. When not adequately diagnosed and treated, hyphema can lead to serious complications, including secondary glaucoma, corneal scarring, amblyopia in children, and even permanent vision loss. Elevated intraocular pressure, resulting from obstruction of the aqueous humor drainage system by erythrocytes, represents one of the most concerning and urgent complications.

From an epidemiological perspective, hyphema is a relatively common condition in ophthalmologic emergency services, being frequently observed in traumatic contexts, but also occurring spontaneously in various clinical situations. The exact prevalence varies depending on the population studied, but is particularly relevant in services that treat ocular trauma.

Correct coding of hyphema in the ICD-11 system is critical for multiple reasons. First, it allows appropriate epidemiological tracking of this condition, facilitating studies of prevalence and incidence. Second, accurate coding is fundamental for resource planning in health systems, since hyphema frequently requires intensive follow-up and may require surgical intervention. Furthermore, the distinction between traumatic and non-traumatic hyphema has significant implications for clinical management, prognosis, and even medico-legal issues, making correct use of the specific codes available in ICD-11 essential.

2. Correct ICD-11 Code

The ICD-11 code for hyphema is 9A80, classified within the category "Disorders of the anterior chamber". This code is specifically designated for cases of hyphema of non-traumatic origin or when traumatic etiology is not the primary focus of coding.

The official description of this code refers simply to "Hyphema", encompassing the presence of blood in the anterior chamber of the eye regardless of quantity, from microhyphemas detectable only on slit lamp examination to macroscopic hyphemas that significantly fill the anterior chamber.

The parent category "Disorders of the anterior chamber" groups various conditions that specifically affect this anatomical structure of the eye, including inflammatory, infectious, structural, and hemorrhagic alterations. This hierarchical organization facilitates navigation within the coding system and helps professionals quickly identify related codes and differential diagnoses.

It is fundamental to understand that code 9A80 represents a significant update compared to previous coding systems, offering greater specificity and clarity in the classification of anterior chamber conditions. The ICD-11 structure allows for more precise differentiation between traumatic and non-traumatic hyphema, an aspect that was not adequately addressed in previous versions of the classification.

3. When to Use This Code

Code 9A80 should be used in specific clinical situations where hyphema is present as a primary or secondary manifestation of non-traumatic conditions. Below, we present detailed practical scenarios:

Scenario 1: Spontaneous Hyphema in Patient with Blood Dyscrasias A patient on oral anticoagulants presents with blurred vision and mild ocular pain. On slit lamp examination, a layer of blood approximately 2mm is observed in the anterior chamber, with no history of trauma. The patient reports waking up with the symptoms. In this case, the hyphema is secondary to coagulation disorder, and code 9A80 is appropriate, accompanied by the code for the underlying systemic condition.

Scenario 2: Post-Operative Hyphema A patient who underwent cataract surgery develops hyphema on the second postoperative day. During follow-up examination, blood is identified in the anterior chamber without signs of additional trauma. Post-surgical hyphema, as a complication of ophthalmologic procedure, should be coded with 9A80, in addition to the appropriate code for the surgical complication.

Scenario 3: Hyphema Secondary to Neovascularization A diabetic patient with proliferative diabetic retinopathy develops rubeosis iridis (iris neovascularization). These newly formed vessels are fragile and may bleed spontaneously, resulting in hyphema. Code 9A80 is used to document the hyphema, together with codes for diabetes and diabetic retinopathy.

Scenario 4: Hyphema in Uveitis A patient with chronic anterior uveitis presents with an acute episode of intense inflammation. During examination, not only cells and flare are observed in the anterior chamber, but also the presence of blood. This inflammatory hyphema should be coded with 9A80, complemented by the specific code for uveitis.

Scenario 5: Hyphema in Intraocular Tumor A patient with iris or ciliary body melanoma may develop spontaneous hyphema due to vascular friability of the tumor. Bleeding may be the first sign of the tumor lesion. In this context, code 9A80 documents the hyphema, while additional codes specify the neoplasm.

Scenario 6: Hyphema in Pigment Dispersion Syndrome Patients with pigment dispersion syndrome or pigmentary glaucoma may, rarely, present with microhyphemas or larger hyphemas due to rupture of iris vessels. When documented, code 9A80 is appropriate, accompanied by the code for the underlying syndrome.

In all these scenarios, the essential criteria for use of code 9A80 include: confirmation of the presence of blood in the anterior chamber through adequate ophthalmologic examination, absence of trauma as the primary cause, and clear documentation of the underlying condition when applicable.

4. When NOT to Use This Code

The most critical distinction in hyphema coding is differentiating between traumatic and non-traumatic causes. Code 9A80 should not be used when hyphema results directly from ocular trauma.

Primary Exclusion Situation: Traumatic Hyphema When a patient presents with hyphema resulting from blunt or penetrating trauma to the eye, the appropriate code is 969612493 (Traumatic hyphema). This distinction is fundamental and must be rigorously observed. For example, a patient who suffered impact from a ball during sports activity and developed hyphema should be coded with the trauma code, not with 9A80. Similarly, hyphemas resulting from physical assault, motor vehicle accidents, falls with direct ocular trauma, or occupational injuries should use the specific trauma code.

Other Exclusion Situations: Code 9A80 should also not be used when the primary diagnosis is another anterior chamber condition that does not involve bleeding. For example, if the patient presents with hypopyon (pus in the anterior chamber) without a hemorrhagic component, other codes are more appropriate. Similarly, when there is only inflammation without visible bleeding, codes for uveitis or other inflammatory conditions should be preferred.

Differentiation of Pseudohyphema: It is important not to confuse true hyphema with pseudohyphema, where material that resembles blood in the anterior chamber is actually composed of other substances such as pigment, tumor cells, or inflammatory material. Although there may be visual overlap, confirmation that the material is effectively blood is necessary for use of code 9A80.

Resolved Hyphema: Once hyphema has completely reabsorbed and is no longer present on examination, code 9A80 should not be used for subsequent visits, unless documenting the history of the condition. In these cases, codes for sequelae or complications may be more appropriate.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

The diagnosis of hyphema requires confirmation through direct ophthalmologic examination. The essential instrument is the slit lamp, which allows detailed visualization of the anterior chamber with adequate magnification. The examination should be performed with the patient seated, ideally, to allow blood to settle inferiorly by gravity, facilitating visualization and quantification.

Diagnostic criteria include: direct visualization of blood in the anterior chamber, documentation of hyphema height (usually measured in millimeters or as a percentage of the anterior chamber filled), assessment of intraocular pressure, and documentation of any associated condition. The evaluation should include detailed history to exclude recent trauma, review of medications (especially anticoagulants), and investigation of systemic symptoms.

Step 2: Verify Specifiers

Although code 9A80 does not have mandatory extensions in ICD-11, clinical documentation should include important specifiers: laterality (right eye, left eye, or bilateral), hyphema severity (microhyphema, grade I with less than one-third of the anterior chamber, grade II with one to half of the chamber, grade III with more than half, or grade IV with total hyphema), presence or absence of rebleeding, and intraocular pressure level.

Duration should also be documented: acute hyphema (present for less than one week), subacute (one to four weeks), or chronic (more than four weeks). Special characteristics such as layered hyphema versus suspended hyphema are also clinically relevant.

Step 3: Differentiate from Other Codes

9A81: Parasites in the anterior chamber of the eye This code is used when there is identification of live or dead parasites in the anterior chamber, such as in cases of onchocerciasis or other ocular parasitoses. The fundamental difference is the presence of the parasitic organism, not simply blood. Although there may be associated inflammatory reaction and even bleeding, the primary diagnosis is parasitic infestation.

9A82: Cyst in the anterior chamber of the eye Cysts in the anterior chamber are encapsulated structures containing fluid, which may be congenital or acquired. Unlike hyphema, which is a collection of free blood, cysts have a defined wall and content that is usually clear or slightly turbid. Differentiation is made through biomicroscopy, which reveals the characteristic cystic structure.

9A83: Flat hypotony of the anterior chamber of the eye This condition refers to flattening of the anterior chamber due to abnormally low intraocular pressure, often following surgery or trauma. The defining characteristic is low pressure with a shallow chamber, not the presence of blood. Although an eye with hyphema may develop hypotony, these are distinct conditions that require different codes when each is the clinical focus.

Step 4: Required Documentation

Adequate documentation to justify code 9A80 should include a specific checklist: description of the slit lamp examination confirming the presence of blood in the anterior chamber, quantification of hyphema, measurement of intraocular pressure, assessment of visual acuity, detailed history excluding recent trauma, documentation of associated systemic or ocular conditions, medications in use (especially anticoagulants), and treatment plan.

Additionally, the following should be recorded: time course of symptoms, presence of pain or photophobia, history of previous episodes, prior ocular surgeries, and any relevant comorbidities such as diabetes, hypertension, or blood dyscrasias. Photographs of the anterior chamber, when available, constitute valuable complementary documentation.

6. Complete Practical Example

Clinical Case

A 68-year-old patient presents to the ophthalmology service with a complaint of blurred vision in the left eye that began two days ago. He reports that upon waking he noticed blurred vision, without significant pain, but with a mild sensation of heaviness in the affected eye. He denies any trauma, fall, or impact to the eye. He does not present with headache, nausea, or other systemic symptoms.

In his past medical history, the patient has had type 2 diabetes mellitus for 15 years, with irregular glycemic control. He was diagnosed with proliferative diabetic retinopathy 6 months ago and has already undergone two sessions of panretinal photocoagulation. He takes metformin, NPH insulin, enalapril, and acetylsalicylic acid 100mg daily.

On ophthalmologic examination, visual acuity in the right eye is 20/30 and in the left eye 20/100. External examination reveals no abnormalities. On slit-lamp biomicroscopy, the right eye shows only discrete changes of initial cataract. In the left eye, blood is observed in the anterior chamber, forming a level of approximately 1.5mm in height (approximately 25% of the anterior chamber height), characterizing grade I hyphema. The iris shows evident neovascularization (rubeosis iridis) with newly formed vessels at the pupillary border and in the iris stroma. The lens shows moderate cataract.

Intraocular pressure measured by applanation tonometry is 18 mmHg in the right eye and 24 mmHg in the left eye. Fundus examination, performed with difficulty due to the hyphema, confirms proliferative diabetic retinopathy with retinal neovessels and areas of previous photocoagulation.

Step-by-Step Coding

Criteria Analysis:

Confirmed presence of blood in the anterior chamber through biomicroscopy
Absence of history of ocular trauma
Identification of underlying cause: rubeosis iridis secondary to proliferative diabetic retinopathy
Hyphema quantified as grade I (1.5mm or approximately 25% of the anterior chamber)
Intraocular pressure slightly elevated, but not at critical levels

Code Selected: 9A80 - Hyphema

Complete Justification: Code 9A80 is appropriate in this case because the patient presents with non-traumatic hyphema. The bleeding in the anterior chamber is secondary to rupture of fragile iris neovessels (rubeosis iridis), which is a known complication of proliferative diabetic retinopathy. The absence of trauma was carefully verified in the history, and the pathophysiologic mechanism is clearly related to diabetic vascular disease.

The hyphema was appropriately documented regarding its grading and characteristics, and intraocular pressure was monitored. The underlying condition (diabetic retinopathy) completely explains the development of hyphema through iris neovascularization.

Complementary Codes:

Type 2 diabetes mellitus with ophthalmologic complications
Proliferative diabetic retinopathy
Rubeosis iridis
Laterality: left eye

The management plan included temporary suspension of acetylsalicylic acid after discussion with the attending physician, rest with elevated head of bed, use of topical corticosteroid and ocular hypotensive agent, in addition to rigorous monitoring of intraocular pressure and hyphema evolution. The patient was counseled about warning signs and scheduled for reevaluation in 24 hours.

7. Related Codes and Differentiation

Within the Same Category

9A81: Parasites in the anterior chamber of the eye

This code should be used when there is documented presence of parasites in the anterior chamber, either through direct visualization on examination or confirmation by other diagnostic methods. The main difference compared to code 9A80 is the nature of the material present in the anterior chamber: parasitic organisms versus blood.

Typical situations include onchocerciasis (river blindness), where microfilariae can be visualized swimming in the anterior chamber, or ocular cysticercosis with presence of cysticercus in the anterior chamber. While hyphema (9A80) presents as blood that tends to settle inferiorly due to gravity, parasites are generally mobile or fixed to intraocular structures, and examination reveals the characteristic morphology of the organism.

9A82: Cyst in the anterior chamber of the eye

Anterior chamber cysts are encapsulated formations that can be congenital (primary iris cysts) or acquired (post-traumatic, post-surgical, or secondary to medications such as miotics). The fundamental difference compared to hyphema is structural: cysts have a defined wall and content that is generally clear or pigmented, but not sanguineous.

On slit lamp examination, a cyst appears as a rounded or oval structure, translucent or opaque, often with characteristic transillumination. Unlike hyphema, which is a free collection of blood that changes position with gravity, the cyst maintains its shape and location. Code 9A82 is used when the cyst is the primary finding, not when there is bleeding in the anterior chamber.

9A83: Flat hypotony of the anterior chamber of the eye

This condition is characterized by abnormally low intraocular pressure (usually below 6-8 mmHg) associated with flattening of the anterior chamber. The anterior chamber becomes shallow, with proximity between cornea and iris, and there may be iridocorneal contact.

The main difference compared to hyphema is that flat hypotony of the anterior chamber refers to an anatomical and pressure alteration, not the presence of blood. Although both conditions may coexist (for example, after trauma or surgery), each requires its specific code when it is the diagnostic focus. In hyphema, the anterior chamber may have normal depth or even increased depth if associated ocular hypertension is present.

Differential Diagnoses

Hypopyon: Collection of pus (leukocytes) in the anterior chamber, typically associated with endophthalmitis or severe uveitis. It differs from hyphema by its white-yellowish coloration versus blood-red, and by the clinical context of infection or intense inflammation.

Pseudohyphema: Appearance similar to hyphema, but composed of non-sanguineous material such as tumor cells (in melanoma or retinoblastoma), pigment (in severe pigment dispersion syndrome), or cellular debris. Differentiation may require anterior chamber paracentesis with laboratory analysis.

Anterior vitreous hemorrhage: Blood in the anterior vitreous can simulate hyphema, but is located posteriorly to the crystalline lens or intraocular lens, not in the anterior chamber. Careful biomicroscopy distinguishes the two conditions.

8. Differences with ICD-10

In ICD-10, hyphema was coded as H21.0 - Hyphema, within category H21 "Other disorders of iris and ciliary body". The transition to ICD-11 brought significant changes in the organization and specificity of coding.

The main change is the explicit separation between traumatic and non-traumatic hyphema in ICD-11. While in ICD-10 the code H21.0 was used for all forms of hyphema, with exclusion notes directing to trauma codes when applicable, ICD-11 created distinct codes: 9A80 for non-traumatic hyphema and 969612493 specifically for traumatic hyphema. This separation better reflects clinical reality, where traumatic versus non-traumatic etiology has important implications for management, prognosis, and medico-legal aspects.

Another relevant change is the hierarchical categorization. In ICD-11, hyphema is clearly positioned within "Disorders of the anterior chamber", a more specific category that facilitates navigation and identification of related conditions. This organization improves coding logic and reduces classification errors.

The practical impact of these changes is significant for health information systems. The separation between traumatic and non-traumatic hyphema allows better epidemiological tracking, identification of injury patterns, and resource planning. For healthcare professionals, the clearer structure of ICD-11 facilitates correct code selection and reduces ambiguities. For research purposes, the increased specificity allows more precise studies on different etiologies and outcomes of hyphema.

9. Frequently Asked Questions

1. How is hyphema diagnosed?

The diagnosis of hyphema is essentially clinical, performed through ophthalmologic examination with a slit lamp. The patient is positioned seated, and the ophthalmologist examines the anterior chamber with appropriate magnification. Blood in the anterior chamber may be visible as a red layer that settles inferiorly due to gravity, or in milder cases, as red blood cells suspended in the aqueous humor. Microhyphemas may require careful examination with high magnification. Beyond direct visualization, the evaluation includes measurement of intraocular pressure, assessment of visual acuity, and complete examination of the anterior and posterior segment of the eye when possible. Laboratory tests are not necessary for the diagnosis of hyphema itself, but may be indicated to investigate underlying systemic conditions.

2. Is treatment available in public health systems?

Treatment of non-traumatic hyphema is generally available in public health systems, as it involves mainly conservative clinical measures. Management includes rest, head elevation, use of anti-inflammatory eye drops, and when necessary, medications for intraocular pressure control. These treatments are relatively accessible and are part of the basic therapeutic arsenal in ophthalmology. In more severe cases requiring surgical intervention, such as anterior chamber washout, the procedure is also typically available in ophthalmology referral centers of public health systems. Regular follow-up is essential and should be guaranteed by the health system.

3. How long does treatment last?

The duration of treatment varies according to the severity of hyphema and the presence of complications. Small hyphemas (grade I) generally reabsorb in 5 to 7 days with conservative treatment. Larger hyphemas may take 2 to 3 weeks for complete resolution. The critical period for intensive monitoring is the first 3 to 5 days, when the risk of rebleeding and ocular hypertension is greatest. During this period, daily or every-other-day evaluations are frequently necessary. After hyphema reabsorption, follow-up can continue for weeks to months to monitor for possible complications such as secondary glaucoma or corneal scarring. Treatment of the underlying condition that caused the hyphema (such as diabetes or blood dyscrasias) is generally long-term.

4. Can this code be used in medical certificates?

Yes, code 9A80 can and should be used in medical certificates when hyphema is the principal diagnosis or significantly contributes to the patient's disability. Hyphema frequently causes significant reduction in visual acuity, photophobia, and discomfort, justifying absence from work activities, especially those requiring adequate visual acuity or involving risk of additional ocular trauma. The duration of absence depends on the severity of hyphema, response to treatment, and the nature of the patient's occupation. Activities that increase intraocular pressure (such as lifting weight) or that place the eye at risk should be avoided during the treatment period. Proper documentation with the ICD-11 code facilitates administrative processes and justifies necessary absence.

5. What is the difference between hyphema and hypopyon?

Although both represent collections of material in the anterior chamber, hyphema and hypopyon are completely distinct conditions. Hyphema is the presence of blood (erythrocytes) in the anterior chamber, while hypopyon is a collection of pus (leukocytes, mainly neutrophils) in the same region. Visually, hyphema presents characteristic red coloration, while hypopyon is white-yellowish. The clinical context also differs: hyphema occurs in bleeding situations (trauma, neovascularization, blood dyscrasias), while hypopyon is associated with severe infectious or inflammatory processes such as endophthalmitis or severe uveitis. Management is completely different, with hypopyon frequently requiring intensive systemic and topical antibiotics.

6. Does hyphema always cause pain?

Not necessarily. The presence of pain in hyphema varies according to the underlying cause and the presence of complications. Small hyphemas without intraocular pressure elevation may be relatively asymptomatic or cause only mild discomfort. Significant pain is generally associated with secondary ocular hypertension, concomitant inflammation, or when there is a traumatic cause (which would not be coded with 9A80). Patients frequently report sensation of heaviness in the eye, photophobia, and blurred vision more than intense pain. However, if intraocular pressure rises significantly, significant pain may occur that requires urgent treatment. The absence of pain does not rule out hyphema, and the presence of pain is not an essential diagnostic criterion.

7. Can children have non-traumatic hyphema?

Yes, although it is less common than in adults. In children, non-traumatic hyphema can occur in contexts such as congenital blood dyscrasias (hemophilia, von Willebrand disease), leukemia, intraocular tumors (retinoblastoma, juvenile xanthogranuloma), congenital vascular malformations, or after ophthalmologic surgeries. Evaluation of hyphema in children requires careful investigation to rule out non-accidental trauma (child abuse), which would be coded differently. Management in children presents additional challenges, including risk of amblyopia if there is prolonged visual deprivation, and difficulty in maintaining adequate rest. Code 9A80 is appropriate when a non-traumatic cause is confirmed.

8. Is it possible to have hyphema in both eyes simultaneously?

Simultaneous bilateral hyphema is rare, but possible in specific situations. Causes include severe blood dyscrasias, complications of bilateral ocular surgeries, or severe systemic conditions such as leukemia with ocular infiltration. Bilateral trauma can occur in high-impact accidents, but would be coded with the traumatic hyphema code, not 9A80. When bilateral hyphema is identified in the absence of trauma, comprehensive systemic investigation is mandatory, including complete hematologic evaluation. Each eye should be coded separately with specification of laterality, and the presence of bilateral hyphema suggests an underlying systemic cause that should also be appropriately coded.

Conclusion

The ICD-11 code 9A80 for hyphema represents an essential tool in the precise classification of anterior chamber conditions of the eye. Proper understanding of when to use this code, differentiating it especially from traumatic hyphema and other anterior chamber conditions, is fundamental for accurate clinical documentation, public health planning, and ophthalmologic research. The systematic approach to coding, considering diagnostic criteria, clinical specifiers, and differential diagnoses, ensures appropriate and consistent use of this code in various clinical contexts.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-04

Hyphema

Share